Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia

July 1, 2013 updated by: Deborah C. Beidel, Milton S. Hershey Medical Center

Social Phobia: Assessment and Treatment of Social Skills

This study will determine whether people with social phobia are deficient in certain social skills.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Social phobia is a debilitating condition that can cause severe social, emotional, educational, and occupational functioning problems. Evidence suggests that individuals with social phobia are deficient in social skills, but the exact skills deficits have not been elucidated. This study will comprise two substudies: one will examine social skills deficits in social phobics and determine how they differ from those of people without social phobia; the other will determine if skills deficits in social phobics can be improved and whether improvements will affect overall social functioning.

Participants in this study will be randomly assigned to one of three groups for 16 weeks: an exposure group, a social skills training and exposure (SET) group, or a wait-list control group. Interviews, self-reports, and simulated role plays will be used to assess the social skills of participants.

Study Type

Interventional

Enrollment (Actual)

379

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Penn State Milton S. Hershey Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of Social Phobia

Exclusion Criteria:

  • Axis II diagnosis of schizoid or schizotypal personality disorder or paranoia
  • Axis II diagnosis of mental retardation, obsessive-compulsive disorder, and personality disorders, except for avoidant personality disorder
  • Instability on any antidepressants
  • Psychotic disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: 3
Placebo
Behavioral: Placebo
Placebo
Active Comparator: 1
Social skills training and exposure
Behavioral: Social Skills Training
Social skills training once per week
Active Comparator: 2
Exposure treatment
Behavioral: Exposure Treatment
Exposure once per week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Phobia Remission
Time Frame: Measured at Month 12
Measured at Month 12
Social Phobia Remission Rate at 6 Month Follow-up
Time Frame: 6 month follow up
Lack of SocialPhobia Diagnosis at 6 month follow-up
6 month follow up

Secondary Outcome Measures

Outcome Measure
Time Frame
Score on the SPAI
Time Frame: Measured at Month 12
Measured at Month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Milton S. Hershey Medical Center

Collaborators

National Institute of Mental Health (NIMH)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2002

Primary Completion (Actual)

March 1, 2008

Study Completion (Actual)

March 1, 2008

Study Registration Dates

First Submitted

November 19, 2003

First Submitted That Met QC Criteria

November 20, 2003

First Posted (Estimate)

November 21, 2003

Study Record Updates

Last Update Posted (Estimate)

July 18, 2013

Last Update Submitted That Met QC Criteria

July 1, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01MH062547 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe